ATE439039T1 - Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen - Google Patents

Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen

Info

Publication number
ATE439039T1
ATE439039T1 AT04702899T AT04702899T ATE439039T1 AT E439039 T1 ATE439039 T1 AT E439039T1 AT 04702899 T AT04702899 T AT 04702899T AT 04702899 T AT04702899 T AT 04702899T AT E439039 T1 ATE439039 T1 AT E439039T1
Authority
AT
Austria
Prior art keywords
mold
test agent
micromanufactured
dimensional
polymer scaffold
Prior art date
Application number
AT04702899T
Other languages
English (en)
Inventor
Joseph P M D Vacanti
Robert Rubin
Wing Cheung
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE439039T1 publication Critical patent/ATE439039T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT04702899T 2003-01-16 2004-01-16 Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen ATE439039T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44053903P 2003-01-16 2003-01-16
PCT/US2004/001098 WO2004065616A2 (en) 2003-01-16 2004-01-16 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications

Publications (1)

Publication Number Publication Date
ATE439039T1 true ATE439039T1 (de) 2009-08-15

Family

ID=32771828

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04702899T ATE439039T1 (de) 2003-01-16 2004-01-16 Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen

Country Status (5)

Country Link
US (2) US7670797B2 (de)
EP (1) EP1589814B1 (de)
AT (1) ATE439039T1 (de)
DE (1) DE602004022508D1 (de)
WO (1) WO2004065616A2 (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759113B2 (en) * 1999-04-30 2010-07-20 The General Hospital Corporation Fabrication of tissue lamina using microfabricated two-dimensional molds
ATE439039T1 (de) 2003-01-16 2009-08-15 Gen Hospital Corp Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen
WO2005089480A2 (en) 2004-03-19 2005-09-29 Stuart Arthur Bateman Activation method
US8741555B2 (en) * 2004-05-14 2014-06-03 Organ Recovery Systems, Inc. Apparatus and method for perfusion and determining the viability of an organ
US7837913B2 (en) * 2004-08-11 2010-11-23 California Institute Of Technology High aspect ratio template and method for producing same
US8075904B2 (en) * 2004-08-11 2011-12-13 California Institute Of Technology High aspect ratio template and method for producing same for central and peripheral nerve repair
WO2006086828A1 (en) 2005-01-21 2006-08-24 Commonwealth Scientific And Industrial Research Organisation Activation method using modifying agent
CA2627288C (en) 2005-10-26 2015-12-15 Jan-Eric W. Ahlfors Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products
US8603806B2 (en) * 2005-11-02 2013-12-10 The Ohio State Universtiy Research Foundation Materials and methods for cell-based assays
US10176887B1 (en) 2005-11-14 2019-01-08 Organ Recovery Systems, Inc. Ex vivo methods for drug discovery, development and testing
JP5421767B2 (ja) * 2006-04-10 2014-02-19 ウィスコンシン・アルムニ・リサーチ・ファウンデーション ヒト胚性幹細胞を使用して薬学的化合物および他の化学物質の毒性を評価するための試薬および方法
US20090239303A1 (en) * 2006-04-24 2009-09-24 Rhoades Lawrence J Ultrasonic Machining Fabrication of Guided Tissue Generation Surfaces and Tissue Scaffolds
EP2029766A4 (de) * 2006-06-08 2010-02-10 Univ North Carolina Pulsung von gallenkammern bei hepatozyten aus sandwich-kulturen
EP3473093B1 (de) 2007-04-12 2020-10-28 The General Hospital Corporation Biomimetisches gefässnetz
US8765364B2 (en) * 2007-05-18 2014-07-01 Lifeline Scientific, Inc. Ex vivo methods for validating substance testing with human organs and/or tissues
US8771930B2 (en) * 2007-05-18 2014-07-08 Lifeline Scientific, Inc. Ex vivo methods for testing toxicity of substances using donated human organs or tissues
US8911995B2 (en) 2007-08-22 2014-12-16 Probiogen Ag Culture system and method for immunogenicity and immunofunction testing in vitro
US8266791B2 (en) * 2007-09-19 2012-09-18 The Charles Stark Draper Laboratory, Inc. Method of fabricating microfluidic structures for biomedical applications
US20110033887A1 (en) * 2007-09-24 2011-02-10 Fang Nicholas X Three-Dimensional Microfabricated Bioreactors with Embedded Capillary Network
US20090234332A1 (en) * 2008-03-17 2009-09-17 The Charles Stark Draper Laboratory, Inc Artificial microvascular device and methods for manufacturing and using the same
US8685432B2 (en) * 2008-03-25 2014-04-01 University Of Utah Research Foundation Controlled release tissue graft combination biomaterials
KR102667365B1 (ko) 2008-07-16 2024-05-21 칠드런'즈 메디컬 센터 코포레이션 마이크로채널을 갖는 기관 모방 장치 및 그 사용 및 제조 방법
US20130323708A1 (en) 2009-07-01 2013-12-05 Massachusetts Institute Of Technology Isolated adult cells, artificial organs, rehabilitated organs, research tools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same
US20110082563A1 (en) * 2009-10-05 2011-04-07 The Charles Stark Draper Laboratory, Inc. Microscale multiple-fluid-stream bioreactor for cell culture
US20110186165A1 (en) * 2009-10-05 2011-08-04 Borenstein Jeffrey T Three-dimensional microfluidic platforms and methods of use and manufacture thereof
US8703424B2 (en) 2010-03-22 2014-04-22 Stemina Biomarker Discovery, Inc. Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics
EP2404672A1 (de) * 2010-07-06 2012-01-11 Universiteit Twente Multiwell-System mit hohem Durchsatz zum Kultivieren von in-vitro oder in-vivo 3D-Gewebekonstrukten, Verfahren zum Herstellen des Multiwell-Systems und Verfahren zur Herstellung von 3D-Gewebekonstrukten aus Zellen, die das Multiwell-System verwenden
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2012071578A2 (en) * 2010-11-24 2012-05-31 Bc Genesis Llc Pharmacology bioassays for drug discovery, toxicity evaluation and in vitro cancer research using a 3d nano-cellulose scaffold and living tissue
EP2681306B1 (de) 2011-02-28 2019-01-09 President and Fellows of Harvard College Zellkultursystem
EP2773955B1 (de) * 2011-11-04 2018-07-18 inRegen Wirkstoffprüfung und potenztests
US20130143230A1 (en) * 2011-12-02 2013-06-06 The Trustees Of The Stevens Institute Of Technology Microfluidic-based cell-culturing platform and method
US20140335496A1 (en) 2011-12-05 2014-11-13 Research Triangle Institute Human conducting airway model comprising multiple fluidic pathways
US20140308688A1 (en) 2011-12-08 2014-10-16 Research Triangle Institute Human emulated response with microfluidic enhanced systems
US9725687B2 (en) 2011-12-09 2017-08-08 President And Fellows Of Harvard College Integrated human organ-on-chip microphysiological systems
US9861663B2 (en) * 2012-02-23 2018-01-09 Technion Research & Development Foundation Ltd. Ex-vivo vascularized implant composition comprising poly-l-lactic acid, polylactic-co-glycolic-acid and olfactory bulb cells
WO2013159939A1 (en) * 2012-04-26 2013-10-31 Technische Universität Berlin Methods for determining and/or monitoring conditions of a three dimensional cell culture system and optical sensor device for conducting said methods
WO2014123978A2 (en) 2013-02-05 2014-08-14 University Of Utah Research Foundation Implantable devices for bone or joint defects
CN105518121A (zh) * 2013-07-12 2016-04-20 中南创发生物科技有限公司 肝脏感染
CN104278008B (zh) 2013-07-12 2020-08-21 北京宏冠再生医学科技有限公司 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途
US9855554B2 (en) 2013-07-22 2018-01-02 President And Fellows Of Harvard College Microfluidic cartridge assembly
US10041045B2 (en) 2013-09-20 2018-08-07 Hackensack University Medical Center Microfluidic three-dimensional osteocyte network reconstructed with microbeads as scaffold
EP3068867B1 (de) 2013-11-16 2018-04-18 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
GB2584034B (en) 2013-12-20 2021-03-24 Harvard College Organomimetic devices and methods of use and manufacturing thereof
WO2015138034A2 (en) 2013-12-20 2015-09-17 President And Fellows Of Harvard College Low shear microfluidic devices and methods of use and manufacturing thereof
WO2015125736A1 (ja) * 2014-02-19 2015-08-27 株式会社モリタ製作所 医療用機器要素、医療用機器、医療用機器構成部品、医療用ハンドピース、医療用機器要素の製造方法、及び医療用切削装置
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
EP3169626A4 (de) 2014-07-14 2018-04-04 President and Fellows of Harvard College Systeme und verfahren zur verbesserten leistung fluidischer und mikrofluidischer systeme
EP3198006B1 (de) 2014-09-26 2021-03-24 Terumo BCT, Inc. Geplante fütterung
US20170307595A1 (en) * 2014-10-22 2017-10-26 The General Hospital Corporation Methods and devices to study metabolism
GB2548740A (en) 2014-11-25 2017-09-27 Harvard College Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
JP6517031B2 (ja) * 2015-02-05 2019-05-22 キヤノンメディカルシステムズ株式会社 医用画像処理装置および磁気共鳴イメージング装置
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN106338423B (zh) 2015-07-10 2020-07-14 三斯坎公司 组织学染色的空间复用
US10202569B2 (en) 2015-07-24 2019-02-12 President And Fellows Of Harvard College Radial microfluidic devices and methods of use
CA2994192C (en) 2015-08-13 2020-06-16 Peking University Induced extended pluripotent stem cells, methods of making and using
CN108138127A (zh) 2015-08-14 2018-06-08 通用医疗公司 用于使用在活组织中提供连通的仿生结构的系统和方法
US10184102B2 (en) 2015-08-26 2019-01-22 EMULATE, Inc. Controlling pressure
US20190282624A1 (en) 2015-11-30 2019-09-19 Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. Improved methods for reprograming non-pluripotent cells into pluripotent stem cells
EP3181700A1 (de) * 2015-12-18 2017-06-21 Safeguard Biosystems Holdings Ltd. Dreidimensionales polymer netzwerk mit darin befindlichen kanälen
US20190127775A1 (en) * 2016-04-22 2019-05-02 Curators Of The University Of Missouri Methods for whole cell antibacterial activity screening and biochemical target identification
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
CA3036378A1 (en) 2016-09-13 2018-03-22 President And Fellows Of Harvard College Methods relating to intestinal organ-on-a-chip
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3630948A4 (de) 2017-05-31 2020-12-30 Beihao Stem Cell and Regenerative Medicine Research Institute Co., Ltd. Verfahren zur chemisch induzierten zelllinienneuprogrammierung
WO2019059702A2 (ko) * 2017-09-25 2019-03-28 아주대학교산학협력단 나노섬유 기반 장기간 초대 간세포 3차원 배양시스템 및 배양방법
KR102062465B1 (ko) 2017-09-25 2020-01-03 아주대학교산학협력단 나노섬유 기반 장기간 초대 간세포 3차원 배양시스템 및 배양방법
WO2019191299A1 (en) 2018-03-27 2019-10-03 San Diego State University In situ partially degradable separation interface for fabrication of complex near net shape objects by pressure assisted sintering
CN117752862A (zh) * 2018-05-25 2024-03-26 通用医疗公司 复杂可植入维生装置的增材制造
CN112805091A (zh) * 2018-09-05 2021-05-14 齐姆特罗尼克斯催化系统股份有限公司 在磁性支架上固定化的酶和微粒体
EP3927417A4 (de) * 2019-02-19 2022-11-16 Iontox LLC Verfahren zur vorhersage der toxizität bei wiederholter dosis mittels einer integrierten organplattform
US10945034B2 (en) 2019-07-11 2021-03-09 International Business Machines Corporation Video fractal cross correlated action bubble transition
WO2021076454A1 (en) * 2019-10-16 2021-04-22 Wisconsin Alumni Research Foundation Mechanically stable and high cell density honeycomb retinal scaffold design for transplantation therapy of photoreceptor cells and retinal pigment epithelium
US20230220354A1 (en) 2020-03-30 2023-07-13 King Abdullah University Of Science And Technology Compositions and methods for controlling cellular identity
US12280540B2 (en) 2020-09-27 2025-04-22 San Diego State University Research Foundation In situ partially degradable separation interface for fabrication of complex near net shape objects by pressure assisted sintering
EP4314244B1 (de) 2021-03-23 2025-07-23 Terumo BCT, Inc. Zellerfassung und -erweiterung
US20240327929A1 (en) * 2021-08-12 2024-10-03 Merck Sharp & Dohme Llc Dosage regimen for administration of belzutifan
EP4408169A4 (de) * 2021-09-30 2025-10-29 Univ Southern California Humanes hepatozytenkulturmedium und konditioniertes medium aus in-vitro kultivierten humanen hepatozyten und verwendungen davon
JP2024539517A (ja) * 2021-10-25 2024-10-28 サテライト バイオサイエンシズ インコーポレイテッド 高アンモニア血症の治療のための操作された組織構築物
US12435312B2 (en) 2022-02-28 2025-10-07 Brown University Quantifying cell-derived changes in collagen synthesis, alignment, and mechanics in a 3D connective tissue model
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN115404165A (zh) * 2022-09-30 2022-11-29 曹毓琳 微器官特异性维持系统

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907687A (en) 1968-12-07 1975-09-23 Baxter Laboratories Inc Plate dialyzer
US3684097A (en) 1970-07-02 1972-08-15 Gen Electric Blood component exchange device
US3839204A (en) 1972-04-27 1974-10-01 Gen Electric Integral blood heat and component exchange device and two flow path membrane blood gas exchanger
FR2197565B1 (de) 1972-08-30 1975-03-07 Rhone Poulenc Ind
US3892533A (en) 1973-03-02 1975-07-01 Sci Med Oxygenator gas distribution header
NL7310808A (nl) 1973-08-06 1975-02-10 Josef Augustinus Elizabeth Spa Inrichting voor het uitwisselen van stoffen tussen twee zich aan weerszijden van een membraan bevindende
US4008047A (en) 1974-12-26 1977-02-15 North Star Research Institute Blood compatible polymers for blood oxygenation devices
DE2622684B2 (de) 1976-05-21 1979-03-15 Licentia Patent-Verwaltungs-Gmbh, 6000 Frankfurt Membranaustauscher
US4191182A (en) 1977-09-23 1980-03-04 Hemotherapy Inc. Method and apparatus for continuous plasmaphersis
US4229290A (en) 1978-03-14 1980-10-21 Raj Ghen M G Compact low surface area dialyzer method and apparatus
JPS6244961B2 (de) 1979-08-21 1987-09-24 Nikorai Sutepanobitsuchi Ridorenko
EP0110733B1 (de) 1982-12-07 1987-08-12 Brian John Bellhouse Vorrichtung zur Übertragung mit einer Membran
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
JPH0342927Y2 (de) 1987-02-09 1991-09-09
IT1202689B (it) 1987-03-25 1989-02-09 Franco Maria Montevecchi Procedimento e dispositivo per la circolazione extracorporea del sangue e per assistenza cardiovascolare
US5225161A (en) 1988-10-20 1993-07-06 Baxter International Inc. Integrated membrane blood oxygenator/heat exchanger
US5316724A (en) 1989-03-31 1994-05-31 Baxter International Inc. Multiple blood path membrane oxygenator
US5204055A (en) 1989-12-08 1993-04-20 Massachusetts Institute Of Technology Three-dimensional printing techniques
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5222982A (en) 1991-02-11 1993-06-29 Ommaya Ayub K Spinal fluid driven artificial organ
US5263924A (en) 1991-09-25 1993-11-23 Baxter International Inc. Integrated low priming volume centrifugal pump and membrane oxygenator
CA2074671A1 (en) 1991-11-04 1993-05-05 Thomas Bormann Device and method for separating plasma from a biological fluid
US5549674A (en) 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US5849553A (en) 1992-07-27 1998-12-15 California Institute Of Technology Mammalian multipotent neural stem cells
CA2119064A1 (en) * 1993-03-17 1994-09-18 Richard A. Berg Dermal-epidermal in vitro test system
DE4320198C1 (de) 1993-06-18 1994-07-14 Fresenius Ag Vorrichtung zum Gasaustausch, insbesondere zum Oxygenieren von Blut
US6200802B1 (en) 1993-10-08 2001-03-13 Arch Development Corporation Human peroxisome proliferator activated receptor gamma: compositions and methods
US5518680A (en) 1993-10-18 1996-05-21 Massachusetts Institute Of Technology Tissue regeneration matrices by solid free form fabrication techniques
US6176874B1 (en) 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US5626759A (en) 1994-08-01 1997-05-06 Regents Of The University Of Colorado Blood treatment device with moving membrane
DE4433376C1 (de) 1994-09-20 1996-04-04 Peter M Prof Dr Kunz Verfahren zum Entrosten von Oberflächen auf organischer Basis und Verfahren zur Herstellung des eingesetzten Mittels
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US7008634B2 (en) 1995-03-03 2006-03-07 Massachusetts Institute Of Technology Cell growth substrates with tethered cell growth effector molecules
BE1009306A5 (fr) 1995-04-28 1997-02-04 Baxter Int Bioreacteur.
US5665596A (en) 1995-07-31 1997-09-09 Becton, Dickinson And Company Device for cell co-culture and method for its use in culturing cells
US6573063B2 (en) 1995-10-04 2003-06-03 Cytoscan Sciences, Llc Methods and systems for assessing biological materials using optical and spectroscopic detection techniques
US5869243A (en) * 1996-03-05 1999-02-09 Rhode Island Hospital Immortalized hepatocytes
US5817343A (en) 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
WO1997045533A1 (en) 1996-05-28 1997-12-04 The Regents Of The University Of Michigan Engineering oral tissues
US6136212A (en) 1996-08-12 2000-10-24 The Regents Of The University Of Michigan Polymer-based micromachining for microfluidic devices
DE69727817T2 (de) 1996-09-05 2005-01-05 Children's Medical Center Corp., Boston Nierenprothese und ihre Verwendung zum Behandeln einer Nierenkrankheit
EP1181355A4 (de) 1997-01-16 2005-05-04 Yissum Res Dev Co Vorrichtung und methode zur durchführung einer biologischen veränderung eines fluides
US6331406B1 (en) 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
CA2227827A1 (en) 1998-01-23 1999-07-23 Unknown In vitro artificial cornea and sclera
EP1064353B1 (de) * 1998-03-18 2002-11-06 Massachusetts Institute Of Technology Vaskularisierte perfundierte anordnungen für mikrogewebe und mikroorgane
US6143293A (en) 1998-03-26 2000-11-07 Carnegie Mellon Assembled scaffolds for three dimensional cell culturing and tissue generation
WO1999052356A1 (en) 1998-04-09 1999-10-21 Charlotte-Mecklenberg Hospital Authority Creation of three-dimensional tissues
WO1999057306A2 (en) * 1998-05-01 1999-11-11 Queen's University At Kingston Method for diagnosing a vascular condition
US20020010550A1 (en) 1998-09-14 2002-01-24 George M. Grass Pharmacokinetic-based drug design tool and method
US6547994B1 (en) 1998-11-13 2003-04-15 Therics, Inc. Rapid prototyping and manufacturing process
US6165486A (en) 1998-11-19 2000-12-26 Carnegie Mellon University Biocompatible compositions and methods of using same
IT1304503B1 (it) 1998-12-24 2001-03-19 In Te C S R L Uso di una membrana selettiva in un dispositivo biomedicale per iltrattamento extracorporeo di sangue e di altri liquidi organici.
US6479072B1 (en) 1999-02-11 2002-11-12 The General Hospital Corporation Microfabricated membranes and matrices
US20020090725A1 (en) 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
WO2000066036A2 (en) 1999-04-30 2000-11-09 Massachusetts General Hospital Fabrication of vascularized tissue using microfabricated two-dimensional molds
US20030129736A1 (en) 1999-07-15 2003-07-10 Eduardo Mitrani Device and method for performing a biological modification of a fluid
EP1226233B1 (de) 1999-08-05 2011-06-29 ABT Holding Company Multipotente erwachsene stammzellen und verfahren zu deren isolierung
US6525242B1 (en) 1999-11-02 2003-02-25 The University Of Connecticut Propagation of human hepatocytes in non-human mammals
US6479064B1 (en) 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
CA2402413A1 (en) 2000-03-14 2001-09-20 The University Of Western Ontario Compositions and methods for affecting osteogenesis
US7776021B2 (en) 2000-04-28 2010-08-17 The Charles Stark Draper Laboratory Micromachined bilayer unit for filtration of small molecules
US6458275B1 (en) 2000-06-05 2002-10-01 Harvard Apparatus, Inc. Multi-well equilibrium dialysis system
AU2001294671A1 (en) 2000-09-25 2002-04-08 The Board Of Trustees Of The University Of Illinois Microfabrication of membranes for the growth of cells
US6607910B1 (en) * 2000-11-13 2003-08-19 Synthecon, Inc. Two chamber cell culture vessel
CN1262313C (zh) 2000-11-28 2006-07-05 爱可森艺术有限公司 在气体交换过程中使气体保持在预定压力范围内的设备
WO2002053193A2 (en) 2001-01-02 2002-07-11 The Charles Stark Draper Laboratory, Inc. Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
NL1017570C2 (nl) 2001-03-12 2002-09-13 Stichting Hogeschool Van Utrec Bloedbehandelingsinrichting.
AU2002257289A1 (en) * 2001-05-17 2002-11-25 The Board Of Trustees Of The Leland Stanford Junior University Device and method for three-dimensional spatial localization and functional interconnection of different types of cells
US7041501B2 (en) * 2001-10-31 2006-05-09 Bristol-Myers Squibb Company Methods of screening for toxicity of test compounds
EP2292278B1 (de) 2001-11-16 2013-04-24 Children's Medical Center Corporation Verbesserung der Funktion von Organen
US20030121594A1 (en) * 2001-12-28 2003-07-03 Brill Russell P. Method for manufacture of tubular multilayer structure from fiber-resin material
AU2003205241A1 (en) * 2002-01-22 2003-09-02 The Penn State Research Foundation Drug candidate screening systems based on micropatterned hydrogels and microfluidic systems
DE10203237B4 (de) 2002-01-28 2006-08-17 Siemens Ag Verfahren zur Magnetresonanz-Bildgebung mit automatischer Anpassung des Messfeldes
AU2003265228A1 (en) 2002-03-12 2003-12-22 Surface Logix, Inc. Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound
WO2004006840A2 (en) * 2002-07-12 2004-01-22 The Regents Of The University Of California Three dimensional cell patterned bioploymer scaffolds and method of making the same
US8147562B2 (en) 2002-09-23 2012-04-03 The General Hospital Corporation Three dimensional construct for the design and fabrication of physiological fluidic networks
US20040147016A1 (en) * 2002-09-30 2004-07-29 Rowley Jonathan A. Programmable scaffold and methods for making and using the same
US7264723B2 (en) 2002-11-01 2007-09-04 Sandia Corporation Dialysis on microchips using thin porous polymer membranes
ATE439039T1 (de) * 2003-01-16 2009-08-15 Gen Hospital Corp Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen
US20050136545A1 (en) * 2003-09-15 2005-06-23 Tecan Trading Ag Microfluidics devices and methods for performing based assays
PT1773978E (pt) * 2004-05-19 2014-05-29 Massachusetts Inst Technology Modelo de doença com células/tecidos tri-dimensionais perfundidos
US20100240086A1 (en) * 2009-03-20 2010-09-23 Dmitry Kashanin Biochip assembly and assay method thereof

Also Published As

Publication number Publication date
US8173361B2 (en) 2012-05-08
US7670797B2 (en) 2010-03-02
EP1589814B1 (de) 2009-08-12
EP1589814A4 (de) 2007-04-25
US20110008765A1 (en) 2011-01-13
WO2004065616A3 (en) 2004-11-18
EP1589814A2 (de) 2005-11-02
WO2004065616A2 (en) 2004-08-05
US20060019326A1 (en) 2006-01-26
DE602004022508D1 (de) 2009-09-24

Similar Documents

Publication Publication Date Title
DE602004022508D1 (de) Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen
Wong et al. Microfluidic assay for the on-chip electrochemical measurement of cell monolayer permeability
EP2245453A4 (de) Zellkulturmatrixsystem für automatisierte tests sowie bedienungs- und herstellungsverfahren dafür
WO2007106868A3 (en) Cell culture devices having ultrathin porous membrane and uses thereof
Ferreira et al. A fast alternative to soft lithography for the fabrication of organ‐on‐a‐chip elastomeric‐based devices and microactuators
DE602005002408D1 (de) Ionenleitende Polymerelektrolytmembran und Produktionsmethode für diesselbe
WO2002066596A3 (de) Vorrichtung und verfahren zur untersuchung von ionenkanälen in membranen
CL2008003452A1 (es) Metodo de monitoreo y control de actividad microbiologica asociada a la superficie en una corriente de proceso que comprende conectar a un flujo de proceso un aparato que comprende una celda de flujo y una sonda de oxigeno disuelto (do); extraer fluido de proceso a la celda; medir variacion de do y controlar actividad microbiologica asociada a la superficie segun esta.
GB0322724D0 (en) A method of determining the identity of an unknown neighbour cell,and apparatus therefor
SG170761A1 (en) Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
WO2007094929A3 (en) Cell culture well-plates having inverted colloidal crystal scaffolds
PT1261480E (pt) Membranas compositas reforcadas nao ondulantes com faces opostas diferentes metodos para producao e sua utilizacao em varias aplicacoes
DE602005019923D1 (de) Gerinnungstestsystem
Babic et al. An easy-to-build and re-usable microfluidic system for live-cell imaging
ATE383573T1 (de) Polymer-elektrolyt, halbzelle für elektrochemische messungen sowie deren verwendung
ATE399997T1 (de) Elektrowetting-zelle und verfahren zu deren herstellung
Ching et al. TapeTech microfluidic connectors: adhesive tape-enabled solution for organ-on-a-chip system integration
SA522431738B1 (ar) غشاء تبادل أيوني لبطارية تدفق أكسدة واختزال
AU2003244864A8 (en) Proton-conducting ceramic membranes on the basis of zirconium phosphates, method for the production thereof, and use thereof in meas and fuel cells
WO2008067015A3 (en) System and method for analyzing dynamics of communications in a network
ATE345500T1 (de) System für die membranpermeationsmessung
Lam et al. Using biomimetic scaffold platform to detect growth factor induced changes in migration dynamics of nasopharyngeal epithelial cells
EP4084169A4 (de) Polymerelektrolytmembran, membranelektrodenanordnung damit und verfahren zur messung ihrer haltbarkeit
WO2021119459A3 (en) Immobilization in flow cells
WO2007022440A3 (en) Resource selection in a communication network

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties